Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.34 EUR 11.48% Market Closed
Market Cap: 36.5m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Capital Expenditures Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Capital Expenditures
-€11k
CAGR 3-Years
18%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Capital Expenditures
-€11.3m
CAGR 3-Years
42%
CAGR 5-Years
-13%
CAGR 10-Years
-8%
G
Genfit SA
PAR:GNFT
Capital Expenditures
-€1.2m
CAGR 3-Years
-111%
CAGR 5-Years
10%
CAGR 10-Years
-13%
Inventiva SA
PAR:IVA
Capital Expenditures
-€540k
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Capital Expenditures
-€4.1m
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
-17%
OSE Immunotherapeutics SA
PAR:OSE
Capital Expenditures
-€250k
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Capital Expenditures?
Capital Expenditures
-11k EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Capital Expenditures amounts to -11k EUR.

What is Gensight Biologics SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
45%

Over the last year, the Capital Expenditures growth was 89%. The average annual Capital Expenditures growth rates for Gensight Biologics SA have been 18% over the past three years , 45% over the past five years .

Back to Top